Medical
Synthetic Cannabinoid Activity Against Colorectal Cancer Cells.
30 μM). Of these compounds, seven were specific for CRC cells, and six were effective in all CRC cell lines tested. Treatment with traditional phytocannabinoids (THC or CBD) was either ineffective or much less potent and only partially efficacious. Treatment with antagonists for the known cannabinoid receptors (alone or in combination) Read more…
Medical
Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells.
Jeong S1, Yun HK2, Jeong YA2, Jo MJ2, Kang SH3, Kim JL1, Kim DY2, Park SH2, Kim BR1, Na YJ2, Lee SI3, Kim HD4, Kim DH4, Oh SC5, Lee DH6.Author information1Division of Oncology/Hematology, Department of Internal Medicine, College of Medicine, Korea University Medical Center, Korea University, Seoul, 08308, Republic of Read more…
Medical
Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells.
korea.ac.kr.6Division of Oncology/Hematology, Department of Internal Medicine, College of Medicine, Korea University Medical Center, Korea University, Seoul, 08308, Republic of Korea; Graduate School of Medicine, College of Medicine, Korea University, Seoul, 08308, Republic of Korea. Electronic address: neogene View the Original article Partage le savoir